The contribution of Cyprus to non-communicable diseases and biomedical research from 2002 to 2013: implications for evidence-based health policy

Table 1 The disease burden (population and percentage values in thousands DALYs) for the world, the 31 European (EUR31) countries and Cyprus (WHO, 2012) [27]

		World		EUR31		Cyprus
		DALYs (000’s)	%	DALYs (000’s)	%	DALYs (000’s)	%
All causes		2,735,162	100	155,304	100	216.1	100
Group 1	Communicable, maternal, perinatal and nutritional conditions	924,686	33.8	7548	4.9	8.1	3.7
Group 2	Non-communicable diseases	1,505,907	55.1	133,904	86.2	184.8	85.5
	Malignant neoplasms	222,567	8.1	30,228	19.5	35.1	16.2
	Trachea, bronchus, lung cancers	38,307	1.40	6611	4.26	7.2	3.34
	Breast cancer	17,644	0.65	2598	1.67	4.2	1.96
	Colon and rectum cancers	17,370	0.64	3492	2.25	2.9	1.34
	Lymphomas, multiple myeloma	9053	0.33	1355	0.87	2.1	0.96
	Prostate cancer	5812	0.21	1420	0.91	2.0	0.91
	Diabetes mellitus	58,810	2.2	4114	2.6	10.6	4.9
	Mental and behavioural disorders	182,841	6.7	20,352	13.1	31	14.4
	Unipolar depressive disorders	76,173	2.78	6428	4.14	11.6	5.37
	Alcohol use disorders	31,998	1.17	3965	2.55	7.3	3.38
	Alzheimer’s disease and other dementias	18,129	0.66	4780	3.08	4.7	2.17
	Anxiety disorders	27,389	1.00	2561	1.65	3.8	1.78
	Drug use disorders	15,120	0.55	1388	0.89	2.0	0.92
	Schizophrenia	14,033	0.51	1230	0.79	1.8	0.82
	Cardiovascular diseases	392,430	14.3	32,500	20.9	41.7	19.3
	Ischaemic heart disease	165,223	6.04	13,882	8.94	20.7	9.57
	Stroke	140,783	5.15	7942	5.11	6.9	3.21
	Respiratory diseases	136,698	5.0	7983	5.1	11.1	5.1
	Chronic obstructive pulmonary disease	92,118	3.37	4763	3.07	4.0	1.85
	Asthma	25,114	0.92	1570	1.01	2.8	1.30
	Other non-communicable diseases	512,560	18.7	38,726	24.9	55	25.5
Group 3	Injuries	304,570	11.1	13,853	8.9	23.2	10.7

ISSN: 1478-4505